TB Alliance – NC009 Clinical Trial
Sponsor: TB Alliance
Principal Investigator - Harriet Mayanja-Kizza, MBChB, MMed, PhD, Uganda-CWRU Research Collaboration
|
Type of Study / Description |
NC-009 pan-phase 2 clinical trial to evaluate the safety and efficacy of a combination of TBAJ-876, pretomanid and linezolid for its potential to shorten and improve treatment for both drug-sensitive and drug-resistant tuberculosis (TB) |
|
Interactions |
Collaborating investigators/staff, utilizing shared infrastructure. |
TB Alliance is a not-for-profit organization dedicated to the discovery, development and delivery of better, faster-acting and affordable tuberculosis drugs that are available to those who need them.
For further details about the TB Alliance and the NC-009 clinical trial, visit their website